HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

2nd International Conference on Orphan Drugs and Rare Diseases

March 13-15, 2025

March 13 -15, 2025 | Rome, Italy

Molecular Genetic Etiology

Molecular Genetic Etiology

The modification of an organism's genome is known as molecular genetics (MG). The term molecular genetics can refer to a fundamental theory alleging that genes control all life processes by producing polypeptides, a more modest basic theory about gene expression and regulation at the molecular level, or an investigative approach used throughout biomedical science that is based on investigative strategies grounded in the basic theory about genes. Molecular genetics makes use of molecular biology's laboratory methods to link changes in the structure and sequence of human genes to functional changes in protein function, and so to health and disease. Many researchers have felt a strong personal responsibility to deliver mutation analyses for diagnosis, carrier detection, and even prenatal diagnosis to the families who have participated in their studies. Genetic testing for rare disorders can be done in a cost-effective manner and is a realistic option for clinical laboratories, according to research.

  • Molecular Genetic Imaging
  • Molecular Genetic Testing
  • Clinical Molecular Diagnostics
  • Epigenetics
  • Somatic Influences on Disease
  • Developmental Transcriptomics
Committee Members
Speaker at Orphan Drugs and Rare Diseases 2025 - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Speaker at Orphan Drugs and Rare Diseases 2025 - Vladlen Slepak

Vladlen Slepak

University of Miami, United States
Speaker at Orphan Drugs and Rare Diseases 2025 - Harsha Rajasimha

Harsha Rajasimha

Jeeva Clinical Trials, Inc, United States
Orphan Drugs 2025 Speakers
Speaker at Orphan Drugs and Rare Diseases 2025 - Vladlen Slepak

Vladlen Slepak

University of Miami, United States
Speaker at Orphan Drugs and Rare Diseases 2025 - Harsha Rajasimha

Harsha Rajasimha

Jeeva Clinical Trials, Inc, United States
Speaker at Orphan Drugs and Rare Diseases 2025 - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Speaker at Orphan Drugs and Rare Diseases 2025 - Melissa Keenan

Melissa Keenan

La Jolla Labs, United States
Tags

Submit your abstract Today

Watsapp